Table 2 Comparison of patient characteristics with and without AF recurrence in paroxysmal AF group.
No recurrence n = 263 | AF recurrence n = 68 | P | |
|---|---|---|---|
Male, n (%) | 137 (52.1) | 33 (48.5) | 0.600 |
Age, years old | 60.6 ± 10.3 | 61.8 ± 9.4 | 0.399 |
History of AF, months | 32.5 ± 24.8 | 42.0 ± 18.0 | 0.001 |
LAD, mm | 38.3 ± 5.0 | 40.4 ± 4.9 | 0.003 |
LVEF, % | 64.8 ± 4.5 | 63.3 ± 7.2 | 0.104 |
Hypertension, n (%) | 149 (56.7) | 38 (55.9) | 0.909 |
Coronary heart disease, n (%) | 21 (8.0) | 5 (7.4) | 0.863 |
Rheumatic heart disease, n (%) | 3 (1.1) | 2 (2.9) | 0.598 |
Cerebral embolism, n (%) | 17 (6.5) | 4 (5.9) | 1.000 |
Diabetes, n (%) | 33 (12.5) | 14 (20.6) | 0.090 |
Smoking, n (%) | 36 (13.7) | 10 (14.7) | 0.829 |
Alcohol, n (%) | 14 (5.3) | 5 (7.4) | 0.727 |
Amiodarone use, n (%) | 62 (23.6) | 17 (25.0) | 0.806 |
BB use, n (%) | 90 (34.2) | 25 (36.8) | 0.695 |
CCB use, n (%) | 33 (12.5) | 8 (11.8) | 0.861 |
ACEI/ARB use, n (%) | 95 (36.1) | 22 (32.4) | 0.562 |
Linear ablations, n (%) | 116 (44.1) | 27 (39.7) | 0.514 |
CFAEs ablations, n (%) | 5 (1.9) | 4 (5.9) | 0.167 |
Cardioversion during ablation, n (%) | 3 (1.1) | 1 (1.5) | 1.000 |
